ModelEdge
Strongbridge Biopharma
0001634432
Filing type
8-K
Filing date
Oct 4, 2021
Updated
Oct 5, 2021 ยท 10:14 AM

Filing

8-KCompleting Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation

Exhibits

EX-99.1Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or CompensationGRAPHICGraphic